Promote real Chinese original research and innovation, and the epigenetic pharmaceutical enterprise Sailan pharmaceutical has completed nearly 200 million yuan of round a financing
On January 4, 2022, cytosin lab therapeutics, which focuses on therapeutic technology and new drug research and development in the field of epigenetics, announced that it would recently complete a round of financing of nearly 200 million yuan. This round of financing is jointly led by zeyue capital and CDH VGC, followed by Kaitai capital, Dawu venture capital, SAIC Hengxu capital, and Haoyi capital as the exclusive financial adviser. It is reported that this round of financing will be used to accelerate the clinical development of multiple epigenetic targeted new drugs on Sailan pharmaceutical pipeline, and further build the epigenetic technology R & D platform of Sailan pharmaceutical epigenplus.
This text is a result of machine translation.
Briefing May 10, 2022 05:23 PM
· Healthcare
Beijing will carry out data collection standardization pilot in the field of digital medicine
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Apr 27, 2022 06:47 PM
· Healthcare
Medtronic's world's first self expanding pulmonary valve was first-class recalled
Apr 18, 2022 06:30 PM
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Technology, Consumer Staples, Real EstateTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Apr 26, 2022 07:38 PM
· Healthcare
Yikai capital released the first set of digital collections of Chinese investment and financing institutions
Briefing Apr 26, 2022 03:52 PM
· Healthcare
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
Briefing Apr 26, 2022 03:43 PM
· Healthcare
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Briefing Apr 26, 2022 11:20 AM
· Healthcare
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Healthcare
R&D of Anti-COVID-19 Drugs is Blooming in China
Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.
Yesterday 02:15 PM
Briefing Apr 26, 2022 11:11 AM
· Healthcare
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Briefing Apr 25, 2022 06:13 PM
· Healthcare
Baiyang pharmaceutical released its first annual report after listing, with double growth in revenue and net profit in 2021
Briefing Apr 25, 2022 09:35 AM
· Healthcare
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
Healthcare
TG ImmunoPharma Raises Hundreds of Mns of CNY in Pre-Series A Financing Round
TG ImmunoPharma, specializing in NK (Natural Killer) cell-based checkpoint immunotherapy drugs, is uncovering the linchpin of the next-generation method of treating cancer with the fresh funding.
May 12, 2022 06:46 PM
In-depth
Healthcare
15 Chinese Companies to Watch in April 2022 – Healthcare
Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China’s healthcare space in April 2022. And the following is a list of deals that we have selected for you, based on a number of criteria including the funding amount, the financial backers, and the segments in which the startups operate.
May 12, 2022 11:03 AM
Briefing Apr 25, 2022 09:30 AM
· Healthcare
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Briefing Apr 25, 2022 09:27 AM
· Healthcare
Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan
Briefing Apr 24, 2022 02:46 PM
· Healthcare
The information center of the State Food and Drug Administration and Baidu Health jointly build a "national authoritative popular science platform for pharmaceutical and mechanical knowledge"
Briefing Apr 22, 2022 11:02 AM
· Healthcare
No chance for scientific innovation board! Lily medical withdrew its registration application and terminated its registration
See more
Read next
In-depth
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.